Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:


Immunovia is a lean, efficient organization of individuals who are passionately committed to increasing the survival rate in pancreatic cancer through early detection. Though small, Immunovia leverages the expertise of team members in Sweden and the United States.